ANDHealth Digital Health Summit

From New Frontiers to the Frontline

Putting Digital Health Innovation into Action


Tuesday 10 December 2024 | 8:30 am – 7:00 pm AEDT

Amazon Building | Level 13, 555 Collins St, Melbourne, VIC

About the Summit
Australia’s leading Digital Health Summit returns to Melbourne this December! Hear from the innovators, investors and industry champions who are changing the healthcare landscape in Australia and beyond.
  
The future of health is digital, with cutting-edge technologies holding immense promise to transform healthcare systems, improve patient outcomes and close the health equity gap. But how can we deliver on this promise and take innovations from new frontiers to the frontline?

With systemic change required in our reimbursement and regulation policies, international keynote speaker Liz Ashall-Payne, CEO of the Organisation for the Review of Care and Health Apps (ORCHA) (UK), will share how Australia can make innovative change in its complex health economy, inspired by what’s happening around the world. ORCHA is the global leader in providing access to trusted digital health technologies, with over 9,000 accredited and compliant products in its library.

Better integration of digital technology into healthcare could save more than $5 billion a year and ease pressures on our healthcare system, yet its full potential remains unrealised. Catherine de Fontenay from the Australian Government’s Productivity Commission will explore how we can harness digital health to reduce healthcare spend and ease system pressures, all while delivering better care.

Healthcare leaders from across the hospital system, primary care and allied health will come together with the pioneers developing digital health technologies to explore what the future of healthcare looks like in action.

Australia’s preeminent investors in digital health and health tech will examine the key international trends driving investment, discuss the transformative potential of digital health technologies, and reveal how they identify which startups are poised for success.

To close the day, we will celebrate the sector’s success and make meaningful connections at ANDHealth’s Industry Christmas Party & Networking Event.

Don’t miss your chance to hear from the best and brightest from across the digital health landscape as we explore how to put innovation into action!

ANDHealth’s Digital Health Summit is kindly supported by Host Partner Amazon Web Services
Speakers
close icon
Bronwyn Le Grice
CEO and Managing Director, ANDHealth

Bronwyn has over 20 years executive experience in health technology commercialisation, venture capital, capital raising and industry advocacy. In 2017 she founded ANDHealth, an organisation that supports digital health companies in Australia by providing education, resources, non-dilutive funding and mentorship to help them navigate the complexities of the healthcare industry.

ANDHealth is now one of Australia’s leading health technology commercialisation organisations with companies participating in its flagship ANDHealth+ program raising $19.70 in new capital and generating $6.70 in new revenues for every dollar invested. ANDHealth manages over $30M in public and private commitments to digital health commercialisation, and provides specialist support to a further $100M of funding managed by Brandon Capital.

Bronwyn was a member of the National Health & Medical Research Council for the 2021-2024 Triennium. She is currently a Non-Executive Director of Lumos Diagnostics Ltd (ASX.LDX) alongside a number of other advisory roles.

Linkedin icon
VIEW PROFILE
Bronwyn Le Grice
CEO and Managing Director, ANDHealth
Read more
VIEW PROFILE
close icon
Liz Ashall-Payne
CEO, ORCHA

Liz Ashall-Payne is an accomplished healthcare leader and the Founding CEO of ORCHA, a global leader in digital health accreditation and distribution services. With a background as a trained NHS Clinician, Liz has been at the forefront of healthcare transformation programs in the NHS, Europe, and North America, leveraging the potential of digital technology to enhance patient health outcomes and drive economic opportunities.

In 2015, Liz established ORCHA, a groundbreaking venture. Under Liz's guidance, ORCHA has experienced remarkable growth, expanding its digital health assessment and distribution services to twelve countries worldwide. Within the UK, ORCHA serves organisations in 70% of NHS regions, positioning itself as a trusted partner in the digital health landscape.

Recognised for her exceptional contributions, Liz Ashall-Payne and ORCHA have received numerous accolades. Liz herself has been honoured as a Tech Trailblazer by the BIMA 100, acknowledged as a Healthcare IT Leader in the HIMSS Future 50, and named Entrepreneur of the Year by prestigious institutions such as the British Chamber of Commerce, Norther Powerhouse, and EY. Additionally, she has been featured within the LDC top 50, further highlighting her influential role in the healthcare and technology sectors.

In addition to her accomplishments at ORCHA, Liz Ashall-Payne actively contributes to the development of future healthcare leaders as a coach for the NHS England Clinical Entrepreneur program. Furthermore, Liz serves as a member of Tech Uk board representing SMES and is the Vice Chair on the Tech UK Health and Social Care Council, where she helps shape policies and initiatives in the intersection of technology and healthcare.

Liz is also an honorary lecturer in the school of medicine at UCLAN, and is a research executive at The University of Warwick

Liz Ashall-Payne's visionary leadership, extensive expertise in healthcare transformation, and dedication to harnessing the potential of digital health make her a prominent figure in the industry, driving positive change and innovation for the benefit of patients and healthcare systems worldwide.

Linkedin icon
VIEW PROFILE
Liz Ashall-Payne
CEO, ORCHA
Read more
VIEW PROFILE
close icon
Catherine de Fontenay
Commissioner, Productivity Commission

Catherine de Fontenay commenced a 5-year term as a full time Commissioner with the Productivity Commission in July 2019.

After completing her PhD in 1998 at Stanford University, Catherine has held faculty positions at the University of New South Wales, then University of Melbourne, with a visiting position at New York University.  Her research on team sin science has been published in Nature Biotechnology.

Catherine leads the Health Productivity stream of research at the PC. She has led work on Measuring Healthcare Productivity, Digital Technologies in Healthcare, Aged Care Employment, and Unpaid Leave for Carers.

Catherine is also currently the President for the Economic Society of Australia.

Linkedin icon
VIEW PROFILE
Catherine de Fontenay
Commissioner, Productivity Commission
Read more
VIEW PROFILE
close icon
Professor Shelley Dolan
CEO, Royal Melbourne Hospital
Linkedin icon
VIEW PROFILE
Professor Shelley Dolan
CEO, Royal Melbourne Hospital
Read more
VIEW PROFILE
close icon
Dr Chris Nave
Managing Director, Brandon Capital Partners and CEO, Brandon BioCatalyst

Chris is a founding partner of Brandon Capital and Chief Executive Officer of Brandon BioCatalyst. Chris was previously the Director of Commercialisation at the Baker IDI Heart and Diabetes Institute, Melbourne, Australia.  Prior to this, Chris was the Manager of the Biotechnology Team at Melbourne Ventures, the commercialisation company of the University of Melbourne. Concurrently he was an Investment Manager for, and on the investment committee of, Uniseed Pty Ltd. Chris has international experience working for the business development group of Leiras Pharmaceuticals in Finland, a wholly owned subsidiary of Schering AG.

Chris is currently a director of; Azura Ophthalmics, Certa Therapeutics, EBR Systems (ASX:EBR), Global Kinetics Corporation, OccuRx, PolyActiva and Que Oncology. He is also an elected board member of the Australian Investment Council, Chair of CUREator and an advisory board member for The WILD Program.

Chris has a Bachelor of Science (Honours) from The University of Melbourne and a PhD in Endocrinology and Physiology from The University of Melbourne. He studied Private Equity and Venture Capital at Harvard Business School.

Linkedin icon
VIEW PROFILE
Dr Chris Nave
Managing Director, Brandon Capital Partners and CEO, Brandon BioCatalyst
Read more
VIEW PROFILE
close icon
Rachel Yang
Partner, Giant Leap
Linkedin icon
VIEW PROFILE
Rachel Yang
Partner, Giant Leap
Read more
VIEW PROFILE
close icon
Dr Megan Robertson
Group Chief Research Officer, St Vincent's Health Australia
Linkedin icon
VIEW PROFILE
Dr Megan Robertson
Group Chief Research Officer, St Vincent's Health Australia
Read more
VIEW PROFILE
close icon
Michelle Burke
Member, Pharmaceutical Benefit Advisory Council & Non-Executive Director, Olivia Newtown John Cancer Research Institute
Linkedin icon
VIEW PROFILE
Michelle Burke
Member, Pharmaceutical Benefit Advisory Council & Non-Executive Director, Olivia Newtown John Cancer Research Institute
Read more
VIEW PROFILE
close icon
Olivia Reeves
Director, Medical Device Software, Therapeutic Goods Administration

Olivia holds Bachelors degrees in both Science and Engineering, specialising in molecular biology and mechatronics, alongside a Masters of Applied Cybernetics from the Australian National University.  

Olivia has extensive experience within both the TGA in the regulation of high risk medical devices, and the Digital Transformation Agency with a focus on enabling better digital services delivered by government. She is currently a director in the Medical Devices Authorisation Branch, responsible for the team that assesses the safety and efficacy of medical device software, including those incorporating AI and ML.

Linkedin icon
VIEW PROFILE
Olivia Reeves
Director, Medical Device Software, Therapeutic Goods Administration
Read more
VIEW PROFILE
close icon
Kate Quirke
Group Managing Director & CEO, Alcidion
Linkedin icon
VIEW PROFILE
Kate Quirke
Group Managing Director & CEO, Alcidion
Read more
VIEW PROFILE
close icon
Grace Lethlean
Chief Product and Partnerships Officer, ANDHealth

As a co-inventor on a patented and ASX listed digital health technology; Grace Lethlean has been actively involved in the development of health technologies from invention, through clinical trials, to commercialisation.

Grace is co-founder and Chief Product Officer of ANDHealth, Australia’s national digital health initiative, accelerating the commercialisation of evidence-based digital health technologies. Grace’s focus is on supporting digital health technologies to meet key investor, partner and customer requirements around clinical and commercial validation.

Grace also supports the sector through numerous state and national Advisory Panels and Committees, is a 2020 SuperStar of STEM, is an inventor on patents in the US and Australia, a published author on digital health commercialisation, a 2022 Churchill Fellow, investigating international best practice in digital health business support and recognised in 2024 as an AFR Women in Leadership.

Linkedin icon
VIEW PROFILE
Grace Lethlean
Chief Product and Partnerships Officer, ANDHealth
Read more
VIEW PROFILE
close icon
Dr Peter Chan
Intensive Care Specialist, Eastern Health

Peter Chan is an Intensive Care Specialist at Eastern Health, Melbourne. He has recently completed a PhD in the validation of medical devices at Monash University. He is interested in the intersection of technology and patient care in the clinical space. He is currently deputy director of research at Eastern Health ICU services and sits on the Human Research and Ethics Committee. He also sits on a number of advisory boards for healthtech startups and is passionate about finding ways of bringing novel technology to the patients that might benefit from them.

Linkedin icon
VIEW PROFILE
Dr Peter Chan
Intensive Care Specialist, Eastern Health
Read more
VIEW PROFILE
close icon
Gavin Fox-Smith
Chair, ANDHealth and CEO, Omnigon

Over his 35 year career Gavin has been a leader and champion of Medical Technology in Australia/NZ and Asia. He has also played lead roles in Industry Bodies, Innovation Initiatives and Not for Profit Boards. Gavin is strong advocate for Gender Equality and Indigenous Engagement.

Gavin is currently CEO of Omnigon, a private Australian company in the Ostomy Care market. He is Chair of ANDHealth (Australia’s National Digital Health Initiative), Board Director for Bowel Cancer Australia and Board Director for SAN Foundation. Gavin is a proud member of the Champions of Change Coalition Health group, sits on SBE Life Sciences Council and ARCS Signature Program Advisory Board, and serves as an Ambassador for Rotary Oceania Medical Aid for Children (ROMAC).

Previously, Gavin was Managing Director Australia/NZ and Vice President Asia Pacific for Johnson & Johnson Medical Devices, Chair of the Medical Technology Association of Australia, Governor of American Chamber of Commerce, Co-Founder/Chair of Macquarie Park Business Coalition (in partnership with United Way) and Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum.

Gavin is a Graduate of the Australian Institute of Company Directors.

Linkedin icon
VIEW PROFILE
Gavin Fox-Smith
Chair, ANDHealth and CEO, Omnigon
Read more
VIEW PROFILE
Frequently Asked Questions
  • Q: Who should attend ANDHealth’s Digital Health Summit?
    A: This event is for industry professionals, C-suite executives, service providers, investors, multinational medical device and pharmaceutical companies, policy makers, decision makers and digital and connected health companies.
  • Q: What does Summit registration include?
    A: ANDHealth Summit registration includes a full day of presentations and panel discussions, morning tea, lunch, afternoon tea and networking throughout the one-day event.
  • Q: Will there be opportunities for networking at the ANDHealth Summit?
    A: During the event, we will have breaks for morning tea, lunch and afternoon tea, and we encourage you to use this time to network with speakers and attendees.
  • Q: Is this a hybrid event?
    A: The ANDHealth Summit is an in-person only event, held in Melbourne.
  • Q: Will the event be recorded?
    A: Due to the frank and fearless nature of the conversations had at ANDHealth Summits and events, we do not record them for future viewing or download.
  • Q: Will attendees receive keynote presentation slides?
    A: Attendees who complete our post-event feedback survey will receive a download link for any available presentation slides, noting that not all speakers will approve their materials for distribution.
  • Q: I’m part of an ANDHealth member organisation, how can I access the event?
    A: ANDHealth member organisations have access to complimentary and discounted pricing. Please contact the relevant person at your organisation for more information.
  • Q: Are tickets refundable?
    A: Refunds are available up to 14 days prior to the event via Humanitix.
Partners

Host Partner

ANDHealth is supported by the Australian Government Department of Health and Aged Care


Partnering with ANDHealth on our Digital Health Summit provides a unique opportunity to be recognised as a leader in Australia's rapidly growing digital health ecosystem.

Please contact the ANDHealth team to discuss ANDHealth Summit sponsorship opportunities.
E: events@andhealth.com.au  
Buy Tickets

Join our
mailing list

Stay up to date on news, programs and events
Thank you, your submission has been received!
Oops! Something went wrong while submitting the form.